Ignore This Picture

Reference List


  1. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37(5):1202-19... (PDF)

  2. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 2008;47(5):1764-72... (PDF)

  3. Blackard JT, Shata MT, Shire NJ, Sherman KE. Acute hepatitis C virus infection: a chronic problem. Hepatology 2008;47(1):321-31... (PDF)

  4. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47(6):2089-111... (PDF)

  5. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49:S13-21... (PDF)

  6. Rotman Y, Brown TA, Hoofnagle JH. Evaluation of the patient with hepatitis B. Hepatology 2009;49:S22-7.. (PDF)

  7. McMahon BJ. The natural history of chronic hepatitis B virus infection.  Hepatology 2009;49:S45-55... (PDF)

  8. Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology 2009;49:S56-60... (PDF)

  9. Mani H, Kleiner DE. Liver biopsy findings in chronic hepatitis B. Hepatology 2009;49:S61-71... (PDF)

  10. Chen CJ, Yang HI, Iloeje UH. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49:S72-84... (PDF)

  11. Taylor BC, Yuan JM, Shamliyan TA, Shaukat A, Kane RL, Wilt TJ. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence. Hepatology 2009; 49:S85-95... (PDF)

  12. Feld JJ, Wong DK, Heathcote EJ. Endpoints of therapy in chronic hepatitis B. Hepatology 2009;49:S96-S102... (PDF)

  13. Perrillo R. Benefits and risks of interferon therapy for hepatitis B. Hepatology 2009;49:S103-11... (PDF)

  14. Dienstag JL. Benefits and risks of nucleoside analog therapy for hepatitis B. Hepatology 2009;49:S112-21... (PDF)

  15. Terrault NA. Benefits and risks of combination therapy for hepatitis B. Hepatology 2009;49:S122-8... (PDF)

  16. Degertekin B, Lok AS. Indications for therapy in hepatitis B. Hepatology 2009;49:S129-37... (PDF)

  17. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009;49:S138-45... (PDF)

  18. Peters MG. Special populations with hepatitis B virus infection. Hepatology 2009;49:S146-55... (PDF)

  19. Hoofnagle JH. Reactivation of hepatitis B. Hepatology 2009;49:S156-65... (PDF)

  20. Andersson KL, Chung RT. Monitoring during and after antiviral therapy for hepatitis B. Hepatology 2009;49:S166-73... (PDF)

  21. Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy. Hepatology 2009;49:S174-84... (PDF)

  22. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 2009;49:S185-95... (PDF)

  23. DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver.  Hepatology 2009;49:1729-64... (PDF)

University of Pennsylvania | Perelman School of Medicine